CANCELED: Nobel laureate neuroscientist Eric Kandel explores art and the mind/brain for the Assembly Series

What happens in your brain when you look at this Klimt painting? A lot more than you might ever guess, according to Nobel laureate neuroscientist Eric Kandel, who will explore the connection between art and the mind/brain in his talk, “The Age of Insight: The Quest to Understand the Unconscious in Art, Mind and Brain from Vienna 1900 to the Present” for the Assembly Series at 5 p.m. Monday, March 3, in Graham Chapel.

Patti wins Sloan Research Fellowship

The Alfred P. Sloan Foundation announced Feb. 17 that Washington University in St. Louis’ Gary Patti has been awarded a 2014 Sloan Research Fellowship. He is among 126 outstanding U.S. and Canadian researchers selected as fellowship recipients this year. Awarded annually since 1955, the fellowships are given to early-career scientists and scholars whose achievements and potential identify them as rising stars, the next generation of scientific leaders.

Inspiring successful entrepreneurs and social innovators with the Suren G. Dutia and Jas K. Grewal Global Impact Award in the Skandalaris Center

A recent gift of $1,025,000 will establish the Suren G. Dutia and Jas K. Grewal Global Impact Award in the Skandalaris Center for Entrepreneurial Studies at Washington University. The endowed fund will receive $1 million, with the remaining $25,000 to support awards made during the current academic year. Applications are being accepted until March 24 for awards to support business ventures aimed at catalyzing social change.

Smoking cessation may improve mental health

Although many health professionals who treat people with psychiatric problems overlook their patients’ smoking habits, new research at the School of Medicine shows that people who struggle with mood problems or addiction can safely quit smoking and that kicking the habit is associated with improved mental health.

Nanoparticles treat muscular dystrophy in mice

Researchers at the School of Medicine have demonstrated a new approach to treating muscular dystrophy. Mice with a form of the disease showed improved strength and heart function when treated with nanoparticles loaded with rapamycin, an immunosuppressive drug recently found to improve recycling of cellular waste.
View More Stories